Andrew J. Last Insider Trading $OCX OncoCyte Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew J. Last.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew J. Last. Andrew J. Last is EVP, Chief Operating Officer in BIO-RAD LABORATORIES, INC. ($BIO) and Chief Commercial Officer in AFFYMETRIX INC ($AFFX) and EVP and GM, GABU in AFFYMETRIX INC ($AFFX) and EVP, Chief Operating Officer in AFFYMETRIX INC ($AFFX) and Chief Operating Officer in INTREXON CORP ($XON) and Director in OncoCyte Corp ($OCX).
Andrew J. Last in OncoCyte Corp
Trading Symbol: OCXIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Andrew J. Last: Director
Holdings: 30,170 shares
Current Value: $164,427
Latest Transaction: Jun 14 2021
$OCX Market Capitalization: $159.33M
$OCX Previous Close: $5.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andrew J. Last in OncoCyte Corp
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFFX, BIO, OCX, XON
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | X | 3.00 | 6,993 | 20,979 | 0 | |
Jun 14 2021 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | X | 3.00 | 6,993 | 20,979 | 30,170 | 23.2 K to 30.2 K (+30.17 %) |
Dec 15 2020 | OCX | OncoCyte Corp | Last Andrew J. | Director | Grant | A | 0.00 | 16,184 | 0 | 23,177 | 7 K to 23.2 K (+231.43 %) |
Jun 19 2020 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 2.38 | 57,000 | 135,660 | 57,000 | |
Jul 19 2019 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 2.12 | 45,000 | 95,400 | 45,000 | |
Jul 19 2019 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 2.12 | 45,000 | 95,400 | 45,000 | |
Sep 04 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 2.40 | 45,000 | 108,000 | 45,000 | |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | P | 3.00 | 6,993 | 20,979 | 6,993 | |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | P | 0.00 | 6,993 | 0 | 6,993 | 0 to 7 K |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | P | 3.00 | 6,993 | 20,979 | 6,993 | |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | P | 0.00 | 6,993 | 0 | 6,993 | 0 to 7 K |
Jun 20 2017 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 5.10 | 20,000 | 102,000 | 20,000 | |
Jun 20 2017 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 5.10 | 6,520 | 33,252 | 6,520 | |
Feb 18 2016 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 3.06 | 20,000 | 61,200 | 20,000 |
Page: 1